Skip to main content

D. E. Shaw & Co., Inc.

Position in ABVX — Abivax S.A.

CIK 1009207 New York, NY

Position in ABVX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$12,040,973
+$6,412,231 QoQ
Shares Held
90,357
+78.7% QoQ
Ownership
0.104%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#79
of 302 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ABVX Over Time

Shares Held

Position Value (USD)

Derivatives in ABVX

reported options exposure · as of Jun 30, 2026
CallValue
$5,330,400
CallShares
40,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

D. E. Shaw & Co., Inc. holds $5,017,559,982 across 217 Biotechnology names. ABVX ranks #68 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ABVX

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,330,400 40,000
2026-06-30 $12,040,973 90,357
2026-03-31 $5,628,742 50,550
2026-03-31 $512,210 4,600
2025-12-31 $2,373,448 17,600
2025-09-30 $2,337,891 27,537